Johnson & Johnson

Latest Headlines

Latest Headlines

J&J buys first Chinese medical device company

Johnson & Johnson ($JNJ) made a big move in China this week with the purchase of its first medical device company in that country. It picked up Guangzhou Bioseal Biotech for an undisclosed sum.

Many U.S. companies not top drugsellers in U.S.

The report says spending on branded drugs in the U.S. increased 2.2% in actual dollars to $258 billion from $252 billion, based on data from IMS Health.

St. Jude, Edwards among those named as potential J&J M&A targets

Analysts think St. Jude Medical ($STJ) and Edwards Lifesciences ($EW) could be eyed by Johnson & Johnson ($JNJ) as potential pickups.

Gorsky starts the marathon task of rehabbing J&J

Johnson & Johnson's Alex Gorsky hung up his hat in the CEO office today. He'll also have to roll up his sleeves.

Fixing OTC production problems is a top priority for new J&J CEO

Resolving manufacturing problems so Johnson & Johnson can get its once well-regarded consumer brands back in consumers hands is Alex Gorsky's first priority as he officially takes the reins as CEO today.

J&J's Gorsky will target device deals for emerging markets

Expect Johnson & Johnson ($JNJ) to start spending some of its $14 billion in cash on medical device deals to help expand its presence in emerging markets once Alex Gorsky becomes CEO.

Novartis remediation drags on longer than expected

In reporting an 8% first-quarter earnings decline to shareholders, Novartis acknowledged the company's inability to meet GMPs at a variety of plants played a big role in that dip.

Pfizer, J&J, Abbott facing shortages of crucial ingredients in Pakistan

The American Business Council has warned authorities that they had better get the matter sorted out or the country will soon face shortages.

J&J gains EU nod for $21.3B Synthes deal

It took a year after the initial announcement, but Johnson & Johnson ($JNJ) finally gained European regulatory approval for its $21.3 billion bid to buy Synthes.

Top 10 Medical Device R&D Budgets

In the face of a sluggish economy barely recovering from its historic collapse in 2008, almost all of the companies made a concerted effort to boost their R&D spending during their 2011 fiscal years.